Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

NCT05546476

Conditions
Anorexia, Body Weight, Body Weight Changes, +34 more
Locations
  • CARTI Conway Conway, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • CARTI North Little Rock North Little Rock, Arkansas, United States
  • CARTI Stuttgart Stuttgart, Arkansas, United States
View all 78 locations
View Trial Details
Completed

Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

NCT04881045

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 43 locations
View Trial Details
Completed

A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants

NCT02075840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • North Valley Hem Onc Med Grp Northridge, California, United States
  • TMPN/ Cancer Care Associates Redondo Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami-Deerfield Beach Deerfield Beach, Florida, United States
View all 97 locations
View Trial Details
Completed

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

NCT02504489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Memorial Health Care System Colorado Springs, Colorado, United States
View all 57 locations
View Trial Details
Completed

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

NCT03409614

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Regeneron Research Site Rancho Mirage, California, United States
  • Regeneron Research Site Riverside, California, United States
  • Regeneron Research Site Whittier, California, United States
  • Regeneron Research Site Orange City, Florida, United States
View all 133 locations
View Trial Details
Completed

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

NCT04087473

Conditions
ALK-Positive Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • The Chinese University of Hong Kong Hong Kong
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • National Cancer Center Singapore Singapore
  • Asan Medical Centre Seoul, South Korea
View Trial Details

Related conditions